Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice

Show simple item record

dc.contributor.author Shome, Avik
dc.contributor.author Mugisho, Odunayo O
dc.contributor.author Niederer, Rachael L
dc.contributor.author Rupenthal, Ilva D
dc.coverage.spatial Switzerland
dc.date.accessioned 2024-03-13T03:52:06Z
dc.date.available 2024-03-13T03:52:06Z
dc.date.issued 2023-07
dc.identifier.citation (2023). Biomedicines, 11(7), 2022-.
dc.identifier.issn 2227-9059
dc.identifier.uri https://hdl.handle.net/2292/67687
dc.description.abstract Experimental autoimmune uveitis (EAU) is the most commonly used animal model to study the progression of chronic uveitis and to test various therapies to treat the disease. However, to accurately evaluate the effectiveness of such treatments, a grading system that combines the latest imaging techniques with definitive quantitative grading thresholds is required. This study aimed to develop a comprehensive grading system that objectively evaluates EAU progression in C57BL/6J mice. EAU was induced following immunisation with interphotoreceptor retinoid-binding protein (IRBP) and pertussis toxin. Weekly fundus and optical coherence tomography (OCT) images were acquired over 12 weeks using a Micron IV imaging system. Each mouse was graded (between 0 to 4) based on changes seen on both the fundus (optic disc, retinal blood vessels and retinal tissue) and OCT (vitreous and retinal layers) images. A total EAU response (with a maximum score of 48) was calculated for each mouse based on the sum of the individual scores each week. Analysis of the clinical scores depicted a gradual increase in inflammatory signs including optic disc and vascular swelling, leukocyte infiltration in the vitreous, lesions in the retina and formation of granulomas and hyper-reflective foci in the retinal layers in EAU mice, with most signs reaching a plateau towards the end of the study period. Development of these signs into sight-threatening complications such as optic disc atrophy, structural damage to the retina and subretinal oedema were noted in 80-90% of mice suggesting consistent disease induction. Overall, a comprehensive and objective grading system encompassing all pathologies occurring in EAU mice was developed to enhance the preclinical evaluation of novel uveitis treatments.
dc.format.medium Electronic
dc.language eng
dc.publisher MDPI
dc.relation.ispartofseries Biomedicines
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
dc.rights.uri https://creativecommons.org/licenses/by/4.0/
dc.subject experimental autoimmune uveitis
dc.subject fundus imaging
dc.subject inflammation
dc.subject optical coherence tomography
dc.subject uveitis
dc.subject 32 Biomedical and Clinical Sciences
dc.subject 3212 Ophthalmology and Optometry
dc.subject Autoimmune Disease
dc.subject Bioengineering
dc.subject Biomedical Imaging
dc.subject Neurosciences
dc.subject Eye Disease and Disorders of Vision
dc.subject 2 Aetiology
dc.subject 2.1 Biological and endogenous factors
dc.subject Eye
dc.subject Science & Technology
dc.subject Life Sciences & Biomedicine
dc.subject Biochemistry & Molecular Biology
dc.subject Medicine, Research & Experimental
dc.subject Pharmacology & Pharmacy
dc.subject Research & Experimental Medicine
dc.subject UVEORETINITIS
dc.subject MOUSE
dc.subject MODEL
dc.subject IRBP
dc.subject EMULSIFICATION
dc.subject DISEASE
dc.subject RETINA
dc.subject H-2(B)
dc.subject 3101 Biochemistry and cell biology
dc.subject 3214 Pharmacology and pharmaceutical sciences
dc.subject 3404 Medicinal and biomolecular chemistry
dc.title Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice
dc.type Journal Article
dc.identifier.doi 10.3390/biomedicines11072022
pubs.issue 7
pubs.begin-page 2022
pubs.volume 11
dc.date.updated 2024-02-08T20:59:36Z
dc.rights.holder Copyright: The authors en
dc.identifier.pmid 37509662 (pubmed)
pubs.author-url https://www.mdpi.com/2227-9059/11/7/2022
pubs.publication-status Published
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype Journal Article
pubs.elements-id 973384
pubs.org-id Medical and Health Sciences
pubs.org-id Medical Sciences
pubs.org-id School of Medicine
pubs.org-id Ophthalmology Department
dc.identifier.eissn 2227-9059
dc.identifier.pii biomedicines11072022
pubs.number ARTN 2022
pubs.record-created-at-source-date 2024-02-09
pubs.online-publication-date 2023-07-18


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics